HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ASP6432

a novel LPA1 antagonist

Also Known As:

potassium 1-(2-((3,5-dimethoxy-4-methyl-N-(3-phenylpropyl)benzamido)methyl)-1,3-thiazole-4-carbonyl)-3-ethyl-2,2-dioxo-2lambda6-diazathian-1-ide

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Imazumi, Katsunori: 2 articles (06/2019 - 03/2019)
2.	Masuda, Noriyuki: 2 articles (06/2019 - 03/2019)
3.	Noguchi, Yukiko: 2 articles (06/2019 - 03/2019)
4.	Ohtake, Akiyoshi: 2 articles (06/2019 - 03/2019)
5.	Sakamoto, Kazuyuki: 2 articles (06/2019 - 03/2019)
6.	Takeda, Masahiro: 2 articles (06/2019 - 03/2019)
7.	Ueshima, Koji: 2 articles (06/2019 - 03/2019)
8.	Sato, Shuichi: 1 article (06/2019)

Related Diseases

1.

Urologic Diseases (Urinary Tract Disease)

03/15/2019 - "Our study results suggest that LPA1 has a significant role in regulating urethral tonus during urine voiding, and highlight the potential of ASP6432 for improving voiding dysfunctions associated with various lower urinary tract diseases."
06/15/2019 - "Our results also suggest the potential of ASP6432 as a novel therapy for the treatment of bladder dysfunction associated with lower urinary tract diseases."

Related Therapies and Procedures

1.	Therapeutics